Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
45,416,671
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
37,791,218
-
Shares change
-
+1,730,428
-
Total reported value, excl. options
-
$241,485,993
-
Value change
-
+$16,508,379
-
Number of buys
-
30
-
Number of sells
-
-14
-
Price
-
$6.39
Significant Holders of THIRD HARMONIC BIO, INC. - Common Stock, par value $0.0001 per share (THRD) as of Q3 2023
57 filings reported holding THRD - THIRD HARMONIC BIO, INC. - Common Stock, par value $0.0001 per share as of Q3 2023.
THIRD HARMONIC BIO, INC. - Common Stock, par value $0.0001 per share (THRD) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37,791,218 shares
of 45,416,671 outstanding shares and own 83% of the company stock.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (10,907,859 shares), ORBIMED ADVISORS LLC (5,779,071 shares), BVF INC/IL (4,365,933 shares), EcoR1 Capital, LLC (2,982,444 shares), GENERAL ATLANTIC, L.P. (2,958,762 shares), TANG CAPITAL MANAGEMENT LLC (1,800,000 shares), COMMODORE CAPITAL LP (1,700,000 shares), BRAIDWELL LP (1,653,991 shares), BlackRock Inc. (1,157,119 shares), and RA CAPITAL MANAGEMENT, L.P. (961,863 shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.